Literature DB >> 6380832

The role of complement and antibody in opsonization and intracellular killing of Candida albicans.

H A Pereira, C S Hosking.   

Abstract

The purpose of this investigation was two-fold. The first, to explore the relationship between ingestion (measured by the phagocytic index method), iodination (measured by the neutrophil iodination micromethod) and intracellular killing (measured by the methylene blue test) of Candida albicans by human polymorphonuclear leucocytes. The second, to determine the effects of complement and antibody on ingestion and intracellular killing of C. albicans. Optimal phagocytosis of C. albicans was observed in fresh untreated human serum. Phagocytosis was present but reduced, in serum depleted of either antibody (by absorption) or complement (by heating at 56 degrees C for 30 min). Whilst in the complete absence of serum, or in FCS the levels were reduced still further. The percentage killed of ingested C. albicans remained constant irrespective of the number of organisms ingested, thus the greater the number ingested, the greater the number killed. Maximal intracellular killing expressed as a percentage of ingested Candida occurred in fresh untreated serum. Intracellular killing did occur in heat-inactivated serum and absorbed serum, although the levels were significantly reduced. The results suggest that C. albicans opsonized in fresh normal PHS are phagocytosed as well as killed more efficiently than those opsonized with only complement or antibody.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6380832      PMCID: PMC1536126     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Influence of antibodies and thermolabile serum factors on the bactericidal activity of human neutrophil granulocytes.

Authors:  C O Solberg; K E Christie; B Larsen; O Tonder
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-04

2.  Candida albicans and the fungicidal activity of the blood.

Authors:  R R Davies; T J Denning
Journal:  Sabouraudia       Date:  1972-11

3.  A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5).

Authors:  M E Miller; U R Nilsson
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

4.  Quantitative leukocyte iodination.

Authors:  S H Pincus; S J Klebanoff
Journal:  N Engl J Med       Date:  1971-04-08       Impact factor: 91.245

5.  A functional comparison of blood and gingival inflammatory polymorphonuclear leucocytes in man.

Authors:  J M Wilton; H H Renggli; T Lehner
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

6.  Interaction of Candida albicans with human leukocytes and serum.

Authors:  R I Lehrer; M J Cline
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

7.  A rapid, inexpensive and easily quantified assay for phagocytosis and microbicidal activity of macrophages and neutrophils.

Authors:  D W Simpson; R Roth; L D Loose
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

8.  Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils.

Authors:  K E Schuit
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

9.  Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.

Authors:  R I Lehrer; M J Cline
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

10.  Assessment of phagocytic and antimicrobial activity of human granulocytes.

Authors:  L Schmid; K Brune
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

View more
  15 in total

1.  Enhanced phagocytosis of Candida species mediated by opsonization with a recombinant human antibody single-chain variable fragment.

Authors:  Melanie Wellington; Joseph M Bliss; Constantine G Haidaris
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

2.  Chromatin-mediated Candida albicans virulence.

Authors:  Jessica Lopes da Rosa; Paul D Kaufman
Journal:  Biochim Biophys Acta       Date:  2011-08-24

3.  Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.

Authors:  A F Lopez; D J Williamson; J R Gamble; C G Begley; J M Harlan; S J Klebanoff; A Waltersdorph; G Wong; S C Clark; M A Vadas
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

4.  Differentiated HL60 promyelocytic leukaemia cells have a deficient myeloperoxidase/halide killing system.

Authors:  G R Pullen; C S Hosking
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

5.  CARD9 deficiencies linked to impaired neutrophil functions against Phialophora verrucosa.

Authors:  Pin Liang; Xiaowen Wang; Runchao Wang; Zhe Wan; Wenling Han; Ruoyu Li
Journal:  Mycopathologia       Date:  2015-03-20       Impact factor: 2.574

6.  Phagocyte-mediated killing of Candida tropicalis.

Authors:  R A Lindemann; C K Franker
Journal:  Mycopathologia       Date:  1991-02       Impact factor: 2.574

7.  Interactions between human natural killer (NK) lymphocytes and yeast cells: human NK cells do not kill Candida albicans, although C. albicans blocks NK lysis of K562 cells.

Authors:  S J Zunino; D Hudig
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

8.  Increased C3 production in human monocytes after stimulation with Candida albicans is suppressed by granulocyte-macrophage colony-stimulating factor.

Authors:  A K Høgåsen; T G Abrahamsen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 9.  Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis.

Authors:  Cristina Cunha Villar; Anna Dongari-Bagtzoglou
Journal:  Expert Rev Mol Med       Date:  2008-10-13       Impact factor: 5.600

Review 10.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.